Not applicable · NCT07226947
BICEP
BIA Monitoring and Exercise for the Prevention of Muscle Loss With Incretin Therapy (BICEP Study)
RecruitingVerified
Trial registry record
What this means
The registry describes the study design and status. This label does not mean results have been reported.
Figure / record sourceLast verified 23 Oct 2026
Registry record
Trial details
- Trial
- BICEP
- ClinicalTrials.gov ID
- NCT07226947
- Indication
- Obesity, Body Composition
- Phase
- Not applicable
- Study type
- Interventional
- Sponsor
- Massachusetts General Hospital
- Enrolment
- 100
- Status
- Recruiting
- Interventions
- Device: Smartwatch activity and body composition monitor; Behavioral: General guidance on recommended exercise
- Comparator
- Not reported
- Eligible ages
- 18 Years – 99 Years
- Locations
- 1 site · United States
- Study start
- 24 Nov 2025
- Primary completion
- 1 Jun 2027
- Study completion
- 1 Jun 2027
Verification
- Last verified
- 23 Oct 2026
- Source
- ClinicalTrials.gov
- Registry last updated
- 30 Dec 2025
Endpoints
Primary
Lean mass (kg)
Secondary
Lean mass index (kg/m2); Appendicular lean mass index (kg/m2); Fat mass index (kg/m2); Fat mass (kg); Visceral adipose tissue (kg); Lean mass/fat mass ratio; Fat free mass; Hand grip strength (kg); 1-minute sit-to-stand; 6-minute walk test; Short Physical Performance Battery frailty score (total points); Physical activity score